The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin

References

• Fraser CG. Optimal analytical performance for point of care testing. Clin Chim Acta 2001;307:37–43.
   PubMed Web of Science ®Google Scholar
• Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409–37.
   PubMed Web of Science ®Google Scholar
• Young DS, Harris EK, Cotlove E. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. IV. Results of a study designed to eliminate long-term analytic deviations. Clin Chem 1971;17:403–10.
   PubMed Web of Science ®Google Scholar
• Ricos C, Iglesias N, Garcia-Lario JV, Simon M, Cava F, Hernandez A, Perich C, Minchinela J, Alvarez V, Domenech MV, Jimenez CV, Bisoca C, Tena R.Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007;44:343–52.
   PubMed Web of Science ®Google Scholar
• Lassen J, Kjeldsen J, Antonsen S, Hyltoft Petersen P, Brandslund I. Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy. Clin Chem 1995; 41:1171–6.
   PubMed Web of Science ®Google Scholar
• Lassen JF, Brandslund I, Antonsen S. International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements. Clin Chem 1995;41:444–7.
   PubMed Web of Science ®Google Scholar
• Carlsen S, Petersen PH, Skeie S, Skadberg O, Sandberg S. Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. Clin Chem Lab Med 2011;49:1501–7.
   PubMed Web of Science ®Google Scholar
• van Geest-Daalderop JHH, Péquériaux NCV, van den Besselaar AMHP. Variability of INR in patients on stable long-term treatment with phenprocoumon and acenocoumarol and implications for analytical quality requirements. Thromb Haemost 2009;102:588–92.
   PubMed Web of Science ®Google Scholar
• van Geest-Daalderop JHH, Kraaijenhagen RJ, van der Meer FJM, van den Besselaar AMHP. Intraindividual variation of the international normalized ratio in patients monitored with a recombinant human thromboplastin. J Thromb Haemost 2010;8:1641–2.
   PubMed Web of Science ®Google Scholar
• van den Besselaar AMHP, Fogar P, Pengo V, Palareti G, Braham S, Moia M, Tripodi A.Biological variation of INR in stable patients on long-term anticoagulation with warfarin. Thromb Res 2012;130: 535–7.
   PubMed Web of Science ®Google Scholar
• Costongs GM, Bas BM, Janson, P. C., Hermans J, Brombacher PJ, van Wersch JW. Short-term and long- term intra-individual variations and critical differences of coagulation parameters. J Clin Chem Clin Biochem 1985;23:405–10.
   PubMedGoogle Scholar
• Dot D, Miro J, Fuentes-Arderiu X. Within-subject and between-subject biological variation of prothrombin time and activated partial thromboplastin time. Ann Clin Biochem 1992;29:422–5.
   PubMed Web of Science ®Google Scholar
• Wada Y, Kurihara M, Toyofuku M, Kawamura M, Iida H, Kayamori Y, Kinoshita S, Hamasaki N. Analytical goals for coagulation tests based on biological variation. Clin Chem Lab Med 2004;41:79–83.
   Google Scholar
• Rudez G, Meijer P, Spronk HM, Leebeek FW, Cate ten H, Kluft C, de Maat MP. Biological variation in inflammatory and hemostatic markers. J Thromb Haemost 2009;7:1247–55.
   PubMed Web of Science ®Google Scholar
• Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;107:1692–711.
   PubMed Web of Science ®Google Scholar
• Owren PA. Thrombotest. A new method for controlling anticoagulant therapy. Lancet 1959;2:754–8.
   PubMed Web of Science ®Google Scholar
• Quick AJ. The prothrombin in hemophilia and obstructive jaundice. J Biol Chem 1935;109:73–84.
   Google Scholar
• Sølvik UØ, Petersen PH, Monsen G, Stavelin AV, Sandberg S. Discrepancies in international normalized ratio results between instruments: a model to split the variation into subcomponents. Clin Chem 2010;56:1618–26.
   PubMed Web of Science ®Google Scholar
• Sølvik UØ, Røraas T, Petersen PH, Monsen G, Stavelin AV, Sandberg S. Effect of coagulation factors on discrepancies in international normalized ratio results between instruments. Clin Chem Lab Med 2012;50: 1611–20.
   PubMed Web of Science ®Google Scholar
• Scandinavian evaluation of laboratory equipment for primary health care (SKUP). Simple Simon® PT: a system for measurement of prothrombin time [P–PT (INR)] manufactured by Zafena AB, Sweden: report from an evaluation in a hospital laboratory organised by SKUP. Accessed December 2013 from: http://www.skup.nuSKUP/2007/57*, Simple Simon PT.
   Google Scholar
• Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69:236–9.
   PubMed Web of Science ®Google Scholar
• Singer DE, Hellkamp AS, Piccini JP, Mahaffey KW, Lokhnygina Y, Pan G, Halperin JL, Becker RC, Breithardt G, Hankey HJ. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial. J Am Heart Assoc 2013;2:e000067.
   PubMed Web of Science ®Google Scholar
• Burdick RK, Graybill FA. Confidence intervals on variance components. Statistics: textbooks and monographs. New York: Marcel Dekker; 1992.
   Google Scholar
• Burdick RK, Borror CM, Montgomery DC. Design and analysis of gauge R & R studies: making decisions with confidence intervals in random and mixed ANOVA models. Alexandria, VA: Philadelphia ASA;2005.
   Google Scholar
• Sokal RR, Rolph FJ. Assumption of analysis of variance. In Biometry, 3rd ed. New York: W. H. Freeman and Company; 1995, pp. 392–450.
   Google Scholar
• Fokkema MR, Herrmann Z, Muskiet FA, Moecks J. Reference change values for brain natriuretic peptides revisited. Clin Chem 2006;52:1602–3.
   PubMed Web of Science ®Google Scholar
• Paternoster R, Mazerolle P, Piquero A. Using the correct statistical test for the equality of the regression coefficients. Criminology 1998;36:859–66.
   Web of Science ®Google Scholar
• NCCLS. Collection, transport and processing of blood specimens for coagulation testing and general performance of coagulation assays. Approved Guideline. NCCLS document H21-A4. Wayne, PA: NCCLS; 2003.
   Google Scholar
• Jerkeman A, Astermark J, Hedner U, Lethagen S, Olsson CG, Berntorp E. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters. Thromb Res 2000;98:467–71.
   PubMed Web of Science ®Google Scholar
• Watala C, Golanski J, Kardas P. Multivariate relationships between international normalized ratio and vitamin K-dependent coagulation-derived parameters in normal healthy donors and oral anticoagulant therapy patients. Thromb J 2003;1:1–7.
   PubMedGoogle Scholar
• Lind SE, Callas PW, Golden EA, Joyner KA, Ortel TL. Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy. Blood Coag Fibrinol 1997;8:48–53.
   PubMed Web of Science ®Google Scholar
• Weinstock DM, Chang P, Aronson DL, Kessler CM. Comparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long-term warfarin therapy and those in the initial phase. Am J Hematol 1998;57:193–9.
   PubMed Web of Science ®Google Scholar
• Gatt A, van Veen JJ, Bowyer A, Woolley AM, Cooper P, Kitchen S, Makris M. Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic international normalized ratio is not due to inflammation. Br J Haematol 2008;142:946–52.
   PubMed Web of Science ®Google Scholar
• Costa IM, Serralheiro AI, Rodrigues M, Alves G, Falcão AC. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy. Biomed Pharmacother 2010;64:130–2.
   PubMed Web of Science ®Google Scholar
• Gulati G, Hevelow M, George M, Behling E, Siegel J. International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy. Arch Pathol Lab Med 2011;135:490–4.
   PubMed Web of Science ®Google Scholar
• Christensen TD, Jensen C, Larsen TB, Christiansen K, Sørensen B. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio. Blood Coagul Fibrin 2009;20:1–8.
   PubMed Web of Science ®Google Scholar
• Testa S, Morstabilini G, Fattorini A, Galli L, Denti N, D’Angelo A. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system. Haematologica 2002;87:1265–73.
   PubMed Web of Science ®Google Scholar
• Scandinavian evaluation of laboratory equipment for primary health care (SKUP). INRatio2: A system for measurement of p-PT (INR) manufactured by Alere Inc. Report from an evaluation organised by SKUP. Accessed December 2013 from: http://www.skup.nuSKUP/2010/80*, INRatio2.
   Google Scholar